Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.15 USD | +6.35% | +3.46% | -8.71% |
May. 23 | CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer | MT |
May. 23 | CRISPR Therapeutics Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.71% | 4.85B | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+37.07% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- CRSP Stock
- News CRISPR Therapeutics AG
- Needham Raises CRISPR Therapeutics' Price Target to $88 From $85, Keeps Buy Rating